MiR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma

被引：0
|
作者：
Ibrahim, Rania
Samaan, Sara
Khella, Heba
Ding, Qiang
Evans, Andrew
Lianidou, Evi
Gabril, Manal
Krylov, Sergey
Jewett, Michael
Bjarnason, Georg
Yousef, George
机构：
[1] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] London Hlth Sci Ctr, London, ON, Canada
[4] Univ Western Ontario, London, ON, Canada
[5] York Univ, Toronto, ON M3J 2R7, Canada
[6] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
919
引用
收藏
页码：231A / 231A
页数：1
相关论文
共 50 条
  • [41] miR-210 is associated to endothelial cell fusion
    Costa, A.
    Casalou, C.
    Caiado, F.
    Igreja, C.
    Dias, S.
    EJC SUPPLEMENTS, 2010, 8 (05): : 180 - 180
  • [42] Biological effect of miR-210 overexpression on renal carcinoma cells
    Nakada, Chisato
    Tsukamoto, Yoshiyuki
    Matsuura, Keiko
    Tung Lam Nguyen
    Hijiya, Naoki
    Uchida, Tomohisa
    Sato, Fuminori
    Mimata, Hiromitsu
    Seto, Masao
    Moriyama, Masatsugu
    CANCER RESEARCH, 2011, 71
  • [43] Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma
    Dias, Francisca
    Teixeira, Ana Luisa
    Ferreira, Marta
    Adem, Barbara
    Bastos, Nuno
    Vieira, Joana
    Fernandes, Mara
    Sequeira, Maria Ines
    Mauricio, Joaquina
    Lobo, Francisco
    Morais, Antonio
    Oliveira, Jorge
    Kok, Klaas
    Medeiros, Rui
    ONCOTARGET, 2017, 8 (61) : 103315 - 103326
  • [44] A novel preoperative inflammatory marker prognostic score in patients with clear cell and non-clear cell renal cell carcinoma.
    Sekar, Rishi Robert
    Patil, Dattatraya
    Pearl, Jeff
    Baum, Yoram
    Kucuk, Omer
    Harris, Wayne B.
    Carthon, Bradley
    Alemozaffar, Mehrdad
    Filson, Christopher Paul
    Ogan, Kenneth
    Master, Viraj A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [45] Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
    Tolkach, Yuri
    Lueders, Christine
    Meller, Sebastian
    Jung, Klaus
    Stephan, Carsten
    Kristiansen, Glen
    ONCOTARGET, 2017, 8 (17) : 28672 - 28682
  • [46] Hepcidin as a prognostic biomarker in clear cell renal cell carcinoma
    Zhou, Zijian
    Wu, Jiajin
    Yang, Yuanyuan
    Gao, Peng
    Wang, Lujia
    Wu, Zhong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (09): : 4120 - +
  • [47] AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma
    Wang, Minglei
    Li, Xuefeng
    Zhang, Jin
    Yang, Qiong
    Chen, Wenqi
    Jin, Weilin
    Huang, Yi-Ran
    Yang, Ru
    Gao, Wei-Qiang
    THERANOSTICS, 2017, 7 (05): : 1100 - 1113
  • [48] c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma
    Gibney, G. T.
    Aziz, S. A.
    Camp, R. L.
    Conrad, P.
    Schwartz, B. E.
    Chen, C. R.
    Kelly, W. K.
    Kluger, H. M.
    ANNALS OF ONCOLOGY, 2013, 24 (02) : 343 - 349
  • [49] MicroRNAs as prognostic markers in clear cell renal cell carcinoma
    Pesta, M.
    Travnicek, I.
    Kulda, V.
    Ostasov, P.
    Windrichova, J.
    Knizkova, T.
    Houfkova, K.
    Bendova, B.
    Hora, M.
    Polivka, J.
    FEBS OPEN BIO, 2024, 14 : 129 - 129
  • [50] Downregulation of Crystallin Lambda 1 is a New Independent Prognostic Marker in Clear Cell Renal Cell Carcinoma
    Feng, Lingsong
    Ding, Guodong
    Zhou, Yang
    Zhu, Haiyuan
    Jiang, Huiming
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2022, 15 : 857 - 866
12345